Schonfeld Strategic Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-114,520
| Closed | -$11.7M | – | 2271 |
|
|
2023
Q2 | $11.7M | Buy |
114,520
+59,557
| +108% | +$6.07M | 0.1% | 311 |
|
|
2023
Q1 | $5M | Sell |
54,963
-207,641
| -79% | -$18.9M | 0.05% | 446 |
|
|
2022
Q4 | $9.98M | Sell |
262,604
-30,896
| -11% | -$1.17M | 0.08% | 305 |
|
|
2022
Q3 | $7.38M | Buy |
+293,500
| New | +$7.38M | 0.06% | 405 |
|
|
2022
Q2 | – | Sell |
-46,300
| Closed | -$1.52M | – | 3023 |
|
|
2022
Q1 | $1.52M | Buy |
+46,300
| New | +$1.52M | 0.01% | 780 |
|
|
2020
Q3 | – | Sell |
-8,650
| Closed | -$1.35M | – | 1689 |
|
|
2020
Q2 | $1.35M | Buy |
8,650
+1,375
| +19% | +$215K | 0.03% | 488 |
|
|
2020
Q1 | $1.05M | Sell |
7,275
-10,301
| -59% | -$1.49M | 0.07% | 353 |
|
|
2019
Q4 | $3.59M | Buy |
17,576
+12,776
| +266% | +$2.61M | 0.09% | 252 |
|
|
2019
Q3 | $385K | Sell |
4,800
-3,600
| -43% | -$289K | 0.01% | 719 |
|
|
2019
Q2 | $792K | Buy |
+8,400
| New | +$792K | 0.03% | 508 |
|
|
2018
Q1 | – | Sell |
-35,000
| Closed | -$991K | – | 998 |
|
|
2017
Q4 | $991K | Buy |
35,000
+10,000
| +40% | +$283K | 0.08% | 311 |
|
|
2017
Q3 | $778K | Buy |
+25,000
| New | +$778K | 0.07% | 309 |
|